We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Editas Medicine
EDIT
$416M
| $13.2M | 0.04% |
1,076,500
+100,000
| +10% | +$1.56M |
|
427
Halozyme
HALO
$9.72B
| $13.1M | 0.04% |
331,600
-58,600
| -15% | -$2.59M |
|
428
Roku
ROKU
$21.2B
| $13.1M | 0.04% |
232,400
+190,000
| +448% | +$14.5M |
|
429
MaxLinear
MXL
$5.93B
| $13.1M | 0.04% |
401,301
+87,500
| +28% | +$3.24M |
|
430
Lumen
LUMN
$6.36B
| $12.9M | 0.04% |
1,769,300
+43,300
| +3% | +$441K |
|
431
Dave & Buster's
PLAY
$359M
| $12.9M | 0.04% |
414,900
-203,900
| -33% | -$7.62M |
|
432
Tronox
TROX
$956M
| $12.9M | 0.04% |
1,049,600
+24,400
| +2% | +$362K |
|
433
Flowserve
FLS
$9.27B
| $12.8M | 0.04% |
528,800
-307,800
| -37% | -$9.31M |
|
434
Algonquin Power & Utilities
AQN
$4.65B
| $12.8M | 0.04% |
1,174,300
+353,500
| +43% | +$4.79M |
|
435
iShares S&P 500 Growth ETF
IVW
$72.3B
| $12.8M | 0.04% |
220,900
-117,600
| -35% | -$7.64M |
|
436
Alnylam Pharmaceuticals
ALNY
$37.5B
| $12.8M | 0.04% |
63,800
+51,400
| +415% | +$9.8M |
|
437
Park Hotels & Resorts
PK
$3.03B
| $12.7M | 0.04% |
1,132,238
+99,600
| +10% | +$1.42M |
|
438
DraftKings
DKNG
$12.1B
| $12.7M | 0.04% |
839,980
-1,358,896
| -62% | -$21.6M |
|
439
Fiverr
FVRR
$402M
| $12.7M | 0.04% |
415,600
-5,000
| -1% | -$178K |
|
440
Cognex
CGNX
$10.2B
| $12.6M | 0.04% |
304,300
+241,100
| +381% | +$10.9M |
|
441
Molina Healthcare
MOH
$10.6B
| $12.5M | 0.04% |
37,900
-9,900
| -21% | -$3.19M |
|
442
Shutterstock
SSTK
$217M
| $12.4M | 0.04% |
248,000
+13,500
| +6% | +$775K |
|
|
GOOS
443
Canada Goose Holdings
GOOS
$879M
| $12.3M | 0.04% |
806,497
-230,600
| -22% | -$4.31M |
|
444
PagerDuty
PD
$760M
| $12.2M | 0.04% |
528,200
-95,800
| -15% | -$2.47M |
|
445
Fortive
FTV
$19.1B
| $12.2M | 0.04% |
277,210
+85,591
| +45% | +$4M |
|
446
Tenable Holdings
TENB
$3.62B
| $12.2M | 0.04% |
349,900
-37,600
| -10% | -$1.58M |
|
447
Autoliv
ALV
$8.73B
| $12.1M | 0.04% |
182,200
-25,800
| -12% | -$2M |
|
448
Steven Madden
SHOO
$3.18B
| $12.1M | 0.04% |
453,400
+76,700
| +20% | +$2.41M |
|
449
Sabre
SABR
$704M
| $12.1M | 0.03% |
2,342,500
-1,468,100
| -39% | -$9.79M |
|
450
Ulta Beauty
ULTA
$20.7B
| $12M | 0.03% |
29,900
+800
| +3% | +$322K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.